Pietro Cassani is the new CEO of Marchesini Group S.p.A. Pietro Cassani is the new CEO of Marchesini Group S.p.A. The Marchesini family and the Board of Directors of Marchesini Group have chosen the former General Director of Sacmi, Mr. Pietro Cassani, to stand as the new Chief Executive... Stellar Biotechnologies appoints pharma and capital markets experts to board of directors Stellar Biotechnologies appoints pharma and capital markets experts to board of directors Stellar Biotechnologies, a leading manufacturer of a key protein utilised in multiple immunotherapy development pipelines targeting cancers, Alzheimer's and lupus, among other... Pharmalink strengthens team in preparation for Phase III trials with Nefecon in IgA nephropathy Pharmalink strengthens team in preparation for Phase III trials with Nefecon in IgA nephropathy Pharmalink AB, a specialty pharma company, announces the appointments of Kari Sandvold, Nora Sjödin and Ann-Kristin Myde and Liselotte Theorell, to key positions in its team... Arch Biopartners appoints Patrick Vink to board of directors Arch Biopartners appoints Patrick Vink to board of directors Arch Biopartners is pleased to announce that Dr Patrick Vink has joined its board of directors, effective 12 December 2016 Serialisation expert Supply Chain Wizard ramps up executive team amid rapid growth in US and abroad Serialisation expert Supply Chain Wizard ramps up executive team amid rapid growth in US and abroad Supply Chain Wizard (SCW), a leading full-service global consulting firm specialising in serialisation and traceability, as well as supply chain strategy and operational... Denny Bros targets Europe with new international sales appointment Denny Bros targets Europe with new international sales appointment Denny Bros recently recruited International Sales Executive, Anne Klermund Concept Life Sciences appoints Tony Johnson as Group Business Development Executive Concept Life Sciences appoints Tony Johnson as Group Business Development Executive Knowledge based, science led business, Concept Life Sciences, has further strengthened its team with the appointment of Tony Johnson as Group Business Development Executive. Drug formulation and delivery expert Dr Joseph Reo appointed as Catalent’s Director of Global Scientific Affairs Drug formulation and delivery expert Dr Joseph Reo appointed as Catalent’s Director of Global Scientific Affairs Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has... New leadership at Bosch Packaging Technology New leadership at Bosch Packaging Technology Dr Stefan König will become president of Bosch Packaging Technology F2G Ltd announces the appointment of John H. Rex, MD, FACP to the position of Chief Medical Officer F2G Ltd announces the appointment of John H. Rex, MD, FACP to the position of Chief Medical Officer Dr Rex is a distinguished research scientist and a key opinion leader in the field of anti-fungal agents Four promoted at SCORR marketing Four promoted at SCORR marketing SCORR Marketing announces the promotions of Lauren Naughton, Ashlee Swanson, Marc Bacon and Holli Kroeker Mission Therapeutics appoints Colin Goddard as Chairman Mission Therapeutics appoints Colin Goddard as Chairman Michael Moore Transitions to Deputy Chairman Acasti Pharma appoints Linda O'Keefe as Chief Financial Officer Acasti Pharma appoints Linda O'Keefe as Chief Financial Officer Linda O'Keefe has over 30 years of financial experience in the life sciences, manufacturing and business Graham Baker appointed Chief Financial Officer Graham Baker appointed Chief Financial Officer Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Graham Baker as Chief Financial Officer. Addex appoints biopharmaceutical industry veteran, Roger G. Mills, M.D., as Chief Medical Officer Addex appoints biopharmaceutical industry veteran, Roger G. Mills, M.D., as Chief Medical Officer Dr Mills adds extensive expertise in Parkinson's disease drug development and commercialisation CFO appointment for Consort Medical CFO appointment for Consort Medical Consort Medical announces that Paul Hayes, Group Finance Director of The Vitec Group, is to succeed Richard Cotton as Consort Medical’s Group Chief Financial Officer (CFO)